# Color Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/color-health

- Industry: Healthcare IT
- Headquarters: Burlingame, US
- Website: www.color.com
- Total disclosed funding: $398M
- Latest round: Series E (Oct 26, 2021)
- Investors on record: 16

## About

Color Health, Inc. is a U.S.-based healthcare company specializing in virtual cancer care, providing comprehensive services like risk assessment, genetic testing, and proactive screening to enhance cancer care accessibility across the nation.Color Health, Inc. is focused on delivering virtual cancer care. Founded in 2014 in Burlingame, California, the company has undergone strategic pivots to enhance its services. The founders include Amit Kapasi and Elad Gil among others. It has successfully raised funding through various rounds, with the most recent being the Series E in October 2021, totaling USD 45.69 mn, reaching a current valuation of USD 4.12 bn.Color Health, Inc. operates the nation's only Virtual Cancer Clinic, which offers comprehensive cancer care services including risk assessments, genetic testing, and screening. The integrated in-house medical team consists of oncologists, primary care physicians, genetic counselors, and care advocates, facilitating early detection and treatment pathways, particularly for underserved populations, including those in rural areas. The company serves employers, health plans, and unions to improve cancer care equity and access.Color Health generates revenue through a subscription-based model, targeting employers and health plans that include its cancer care solutions in employee benefits. Clients typically pay for comprehensive access to services like assessments, screening, and testing, allowing for direct billing for each service utilized, which supports better health outcomes and aligns with cost-saving objectives.In October 2021, Color Health, Inc. secured USD 45.69 mn in Series E funding, co-led by Kindred Ventures and T. Rowe Price. The funds will be utilized to accelerate the expansion of accessible public health infrastructure. The company is poised to launch new products aimed at enhancing cancer care access, with specific plans for geographic expansion into underserved markets in the U.S. over the coming years.

## Funding rounds

- Series E, Oct 26, 2021, $46M — T Rowe Price, General Catalyst Partners, Viking Global Investors, Emerson Collective, Kindred Ventures
- Series D, Dec 17, 2020, $127M — T Rowe Price, General Catalyst Partners, Viking Global Investors
- Series D, Jan 14, 2020, $75M — T Rowe Price, Viking Global Investors
- Series C, Nov 14, 2017, $37M — CRV, General Catalyst Partners, Emerson Collective
- Series C, Aug 3, 2017, $52M — CRV, General Catalyst Partners, Pegasus Tech Ventures, LionTree, Emerson Collective, LeFrak
- Series B, Aug 16, 2016, $39M — General Catalyst Partners, Shasta Ventures, Khosla Ventures, Caffeinated Capital, 8VC, Brainchild Holdings, Emerson Collective, LeFrak
- Series A, Feb 11, 2015, $23M — Khosla Ventures, Formation8, Emerson Collective, LeFrak
- Seed, Jan 1, 2015 — SV Angel

## Investors

- SV Angel (https://capitalatlas.ai/funds/sv-angel) — Seed
- Khosla Ventures (https://capitalatlas.ai/funds/khosla-ventures) — Series A, Series B
- Formation8 (https://capitalatlas.ai/funds/formation8) — Series A
- Emerson Collective — Series A, Series B, Series C, Series E
- LeFrak (https://capitalatlas.ai/funds/lefrak) — Series A, Series B, Series C
- General Catalyst Partners (https://capitalatlas.ai/funds/general-catalyst-partners) — Series B, Series C, Series D, Series E
- Shasta Ventures (https://capitalatlas.ai/funds/shasta-ventures) — Series B
- Caffeinated Capital (https://capitalatlas.ai/funds/caffeinated-capital) — Series B
- 8VC (https://capitalatlas.ai/funds/8vc) — Series B
- Brainchild Holdings (https://capitalatlas.ai/funds/brainchild-holdings) — Series B
- CRV (https://capitalatlas.ai/funds/crv) — Series C
- Pegasus Tech Ventures (https://capitalatlas.ai/funds/pegasus-tech-ventures) — Series C
- LionTree (https://capitalatlas.ai/funds/liontree) — Series C
- T Rowe Price (https://capitalatlas.ai/funds/t-rowe-price) — Series D, Series E
- Viking Global Investors (https://capitalatlas.ai/funds/viking-global-investors) — Series D, Series E
- Kindred Ventures (https://capitalatlas.ai/funds/kindred-ventures) — Series E